First early cancer-detection company to use microbial biomarkers in diagnostics
SAN DIEGO, Aug. 13, 2020 /PRNewswire/ — Micronoma, an early cancer-detection biotech that seeks to develop and commercialize a minimally invasive, microbiome-based metho… […]
The funds enable ImmunoScape to bring its unique immune-profiling capability to major biopharma companies globally, accelerating development of vital immunotherapies and other medicines
SINGAPORE and SAN DIEGO, Aug. 12, 2020 /PRNewswire/ — ImmunoSc… […]
SAN DIEGO, July 28, 2020 /PRNewswire/ — BioTheryX, Inc., a clinical stage biotechnology company harnessing the power of protein modulation to treat difficult diseases, today announced it has closed a $35 million Series D financing. The round was l… […]
Proceeds will advance CAB-AXL and CAB-ROR2 clinical programs into Phase 2 trials, CAB-CTLA-4 Phase 1 trial, and additional CAB development programs
SAN DIEGO, July 15, 2020 /PRNewswire/ — BioAtla, Inc., a global clinical-stage biotechnology company… […]
SAN DIEGO, June 25, 2020 /PRNewswire/ — Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to utilizing proprietary gene engineering platform technologies to create next generation cell and gene therapeutics with the c… […]
SAN DIEGO, June 16, 2020 /PRNewswire/ — Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage oncology therapeutics company developing drugs to treat cancers with the greatest medical need for new treatment options, including KRAS-mutated colorec… […]
SAN DIEGO, June 8, 2020 /PRNewswire/ — Origami Therapeutics http://origamitherapeutics.com, an early stage biotech company taking a precision medicine approach to find disease-modifying treatments for neurodegenerative diseases caused by protein fo… […]
Company Focused on Finding an Effective Solution for Acute Kidney Injury (AKI)
CARLSBAD, Calif., May 28, 2020 /PRNewswire/ — Venture.co Brokerage Services, LLC (“VENTURE.co”) today announces a private capital investment opportunity into HemaFlo Ther… […]
Financing advances clinical development of two innovative product candidates for the treatment of life-threatening diseases affecting patients with compromised immune systems
SAN DIEGO, May 19, 2020 /PRNewswire/ — Amplyx Pharmaceuticals, a biotech c… […]
Funding Will Accelerate the Development of ChromaCode Assays for Infectious Disease, Targeted Toward Resource-Limited Communities Worldwide
CARLSBAD, Calif., May 19, 2020 /PRNewswire/ — ChromaCode, Inc., a company redefining molecular testing throu… […]
SAN DIEGO, April 1, 2020 /PRNewswire/ — Aspen Neuroscience, a private biotechnology company developing the first autologous neuron replacement therapy to treat Parkinson disease, today announced the close of its Series A funding round of $70 millio… […]
“The Future of Successful Investment in Biotech? Wednesday, July 22, 7:00am – 9:00am Hyatt Regency La Jolla at Aventine Sponsored by Mayer Hoffman McCann, Pillsbury Winthrop Shaw Pittman, and Porter Novelli Life Sciences The hope […]
Copyright © 2021 Biotech Networks, LLC
